BioAge Labs, Inc. (BIOA)
12.78
+0.10
(+0.79%)
USD |
NASDAQ |
Dec 11, 16:00
12.50
-0.28
(-2.19%)
After-Hours: 18:37
BioAge Labs EPS Diluted (Quarterly): -0.5626 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Perspective Therapeutics, Inc. | -0.3495 |
| Electromed, Inc. | 0.246 |
| Xtant Medical Holdings, Inc. | 0.0087 |
| VolitionRX Ltd. | -0.0497 |
| Myomo, Inc. | -0.0869 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -20.17M |
| Revenue (Quarterly) | 2.054M |
| Total Expenses (Quarterly) | 22.22M |
| Enterprise Value | 176.00M |
| Gross Profit Margin (Quarterly) | 97.61% |
| Profit Margin (Quarterly) | -982.0% |
| Earnings Yield | -16.54% |
| Normalized Earnings Yield | -16.61 |